Nicholls, Stephen J.
Funding for this research was provided by:
Monash University
Article History
Accepted: 5 May 2024
First Online: 8 June 2024
Declarations
:
: Open Access funding enabled and organized by CAUL and its Member Institutions.
: S.J.N. has received research support from AstraZeneca, Amgen, Anthera, CSL Behring, Cerenis, Cyclarity, Eli Lilly, Esperion, Resverlogix, New Amsterdam Pharma, Novartis, InfraReDx and Sanofi-Regeneron and is also a consultant for Amgen, Akcea, AstraZeneca, Boehringer Ingelheim, CSL Behring, Eli Lilly, Esperion, Kowa, Merck, Takeda, Pfizer, Sanofi- Regeneron, Vaxxinity, CSL Sequiris, and Novo Nordisk.
: SJN wrote, edited and reviewed this manuscript.
: Data sharing not applicable to this article as no datasets were generated for this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.